Vassiliou, A.G.; Tsipilis, S.; Keskinidou, C.; Vrettou, C.S.; Jahaj, E.; Gallos, P.; Routsi, C.; Orfanos, S.E.; Kotanidou, A.; Dimopoulou, I.
Lactate and Lactate-to-Pyruvate Ratio in Critically Ill COVID-19 Patients: A Pilot Study. J. Pers. Med. 2022, 12, 171.
https://doi.org/10.3390/jpm12020171
AMA Style
Vassiliou AG, Tsipilis S, Keskinidou C, Vrettou CS, Jahaj E, Gallos P, Routsi C, Orfanos SE, Kotanidou A, Dimopoulou I.
Lactate and Lactate-to-Pyruvate Ratio in Critically Ill COVID-19 Patients: A Pilot Study. Journal of Personalized Medicine. 2022; 12(2):171.
https://doi.org/10.3390/jpm12020171
Chicago/Turabian Style
Vassiliou, Alice G., Stamatios Tsipilis, Chrysi Keskinidou, Charikleia S. Vrettou, Edison Jahaj, Parisis Gallos, Christina Routsi, Stylianos E. Orfanos, Anastasia Kotanidou, and Ioanna Dimopoulou.
2022. "Lactate and Lactate-to-Pyruvate Ratio in Critically Ill COVID-19 Patients: A Pilot Study" Journal of Personalized Medicine 12, no. 2: 171.
https://doi.org/10.3390/jpm12020171
APA Style
Vassiliou, A. G., Tsipilis, S., Keskinidou, C., Vrettou, C. S., Jahaj, E., Gallos, P., Routsi, C., Orfanos, S. E., Kotanidou, A., & Dimopoulou, I.
(2022). Lactate and Lactate-to-Pyruvate Ratio in Critically Ill COVID-19 Patients: A Pilot Study. Journal of Personalized Medicine, 12(2), 171.
https://doi.org/10.3390/jpm12020171